Showing posts with label Maryland. Show all posts
Showing posts with label Maryland. Show all posts

Saturday, February 8, 2014

Truesdail Laboratories in California receives a 5-year deal to test blood and urine samples of horses racing at Maryland tracks

Blood and urine samples from horses running in races at Maryland tracks will be tested by Truesdail Laboratories in Tustin, Calif, under a new 5-year deal that ended the state racing commission’s longtime relationship with a state testing lab.

Sunday, December 1, 2013

Thursday, February 28, 2013

Maryland Senate Hearing Set for 3/13/13 1:00 on Proposed Legislation Relating to Compounding


Requiring a sterile compounding facility to hold a sterile compounding permit issued by the State Board of Pharmacy before the sterile compounding facility may perform sterile compounding in the State; providing that a sterile compounding permit is required in addition to and does not replace other permits or licenses; requiring a sterile compounding facility that performs sterile compounding outside the State to hold a sterile compounding permit issued by the Board under specified circumstances; etc.







For more information see here

Saturday, February 16, 2013

Maryland Board of Pharmacy Meeting Feb. 30, 2012; Agenda Has Been Posted


Board of Pharmacy Meeting Notices
The Next Public Board Meeting: February 20, 2012, 9:30 AM
Location: DHMH Metro Building
Address: 4201 Patterson Avenue
Baltimore, MD 21215
Room:
Agenda: February Agenda 
Date Posted: 02/15/2012
For More Information: (410) 764-3460
dhmh.mdbop@maryland.gov

Monday, December 17, 2012

Maryland Board of Pharmacy December 19, 2012 Agenda Has Numerous Items Relating To Compounding


For example, the agenda list:

REQUESTS FOR RECOMMENDATIONS:
1) November 7, 2012 Meningitis Briefing before HGO – Follow
up for Chairman Hammen
2) Request from Marie Grant for Congressman’s Cummings’ Office
for Board’s views on reporting requirements for pharmacies that
distribute to pharmacies or to distributors and pharmacies.
3) Secretary’s requests Board consideration of 6 additional steps to
ensure safer compounding pharmacies.
Sharfstein request for more action for compounding 121012


And the agenda list the following related to Patient Specific Prescriptions:

Patient Specific Prescriptions - Opthalmic ASC
Draft Board Response – patient specific compounding  - Dulaney
4) Claudia McGrath, Piney Orchard Surgery Center
Prescriptions for compound drugs - Ambulatory Surgery Center
Draft Board Response – patient specific compounding -
Piney
5) Mel Rubin
Compoundingk pharmacies - Mel Rubin
Draft Board Response – patient specific compounding - Rubin

Complete Agenda can be viewed here


Tuesday, December 4, 2012

Legislators to look at drug shortages Doctors, medical administrators testify at hearing



The staff at Anne Arundel Medical Center considered canceling some surgeries on a recent weekend because the hospital was running low on a common drug used to help bring people out from under anesthesia.
It is the kind of problem hospitals and doctors around the country continue to face as drug shortages that began a few years ago threaten the way everyday medicine is practiced.
The problem has persisted even after calls from Congress and President Barack Obama to find a solution and a federal investigation that found widespread abuses in the drug manufacturing and distribution system. Maryland lawmakers are jumping into the fray with plans to introduce legislation to tackle the issue at the state level.
On Tuesday, the Joint Committee on Health Care Delivery and Finance held a hearing to gather insights on what role the state could play.
Dr. Barry Meisenberg, chair of quality improvement and health systems research at Anne Arundel Medical Center, said the shortages force doctors to make tough decisions on how to treat patients. The hospital decided not to cancel surgeries that weekend, but Meisenberg said the issue was real.
"I used this as an example of how serious this has become," Meisenberg said.